S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Harrow Shares Jump 15% After Revenue Tops Estimates

Harrow shares rose 15% to $31.47 in after-hours trading Monday after the biotechnology company reported third-quarter revenue of $99.3 million, above analysts’ $98.6 million estimate, and earnings per share of 25 cents, compared with expectations of 19 cents.

Harrow Shares Jump 15% After Revenue Tops Estimates

The company’s profit was $9.8 million, up from $1 million a year earlier. The latest figure included a $5 million gain from a litigation settlement. Revenue increased from $71.6 million in the year-earlier period, while branded revenue climbed 62% to $83.5 million.

Harrow reaffirmed its full-year revenue forecast of $350 million to $365 million. It projected adjusted earnings before interest, taxes, depreciation and amortization of more than $40 million for the year, including more than $33 million in the fourth quarter.

“We expect the fourth quarter to be Harrow’s strongest on record and that second-half revenue will exceed the high end of what we contemplated in March,” Chief Executive Officer Mark Baum said.

Harrow’s shares closed Monday at $27.47, up 2.2% on the day but down 44% so far this year.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!